TRAVOPROST OPHTHALMIC SOLUTION, 0.004%

travoprost ophthalmic solution 0.004% · Mylan Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TRAVOPROST OPHTHALMIC SOLUTION, 0.004%, covering 2017-07-07 to 2024-08-07. Get the full timeline:

Most recent: FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION, 0.004% — Supplemental Application (Mylan Pharmaceuticals Inc.)